Treatment of low-risk myelodysplastic syndromes with high-dose daily oral cholecalciferol (2000-4000 IU vitamin D3) [1]

I. Molnár, N. Stark, J. Lovato, B. L. Powell, J. Cruz, D. D. Hurd, J. S. Mathieu, T. C. Chen, M. F. Holick, S. Cambra, R. P. McQuellon, G. G. Schwartz

Research output: Contribution to journalLetterpeer-review

8 Scopus citations
Original languageEnglish (US)
Pages (from-to)1089-1092
Number of pages4
Issue number5
StatePublished - May 2007
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this